Topic: induced pluripotent stem cells
Scientists at Stanford University believe stem cells can teach the immune system to recognize and attack cancer.
Astellas has bought out a U.S. biotech that wants to ensure cell therapy products aren’t rejected by a patient’s immune system.
A team at Duke University has created the first functioning human muscle from skin cell-derived induced pluripotent stem cells.
Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.
The product of a merger of Pluriomics and Axiogenesis, iPSC company Ncardia has signed licensing deals with Roche and Evotec.
Scientists from the Wellcome Trust Sanger Institute have created a new type of stem cell that retains the ability to develop into any type of cell.
Evotec will use Censo's patient-derived induced pluripotent stem cells for neurological drug discovery.
Houston Methodist researchers have unpacked the mechanism by which pluripotency is induced in stem cells.
Induced pluripotent stem cell (iPSC) specialist Axiogenesis AG has partnered with ion channel CRO Metrion Biosciences to develop human iPSC-derived cardiomyocytes and neurons for drug discovery applications.
Third Rock Ventures is launching Fulcrum Therapeutics, which works to control gene expression via small molecules, with a Series A round of $55 million.